Vertex' $2.7B in CRE Value

Can you pick anyone out through the confetti? Vertex Pharmaceuticals is generating $2.7B in real estate activity at Fan Pier with the $900M, 1.1M SF build-to-suit complex that The Fallon Company started building for it in June. Add to that the lease  payments (as much as $1.8B-plus operating costs over 15 years)and it's easy to see why the summer groundbreaking looked and felt more like New Year?s Eve. The life science company's relo from its longtime Cambridge HQ has also infused confidence among other developers who have a few billion dollars more in projects in the works at the Seaport.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

From Pandemic Darling To Cautionary Tale: Pickleball Clubs Face A Reckoning After Betting Big On Retail Space

'Distress Is Finally Trading': Investors Chasing Big Discounts On Boston Office

140-Acre Attleboro Golf Course Hits Market, Pitched For Redevelopment

Foundry Robotics Leaves San Francisco For New East Bay HQ

Alexandria Sells Stakes In Megacampuses To Weather Life Sciences Downturn

Nonprofit Developer Buys Mattapan Site For Affordable Housing: The Boston Deal Sheet

Tenant Rep Firm Expands To Philly, Hires Industry Veteran

Downtown Office Tower Sells At Foreclosure Auction For $260M

Data Centers Lose The Top Spot, San Francisco Jumps 40 Places: 9 Takeaways From ULI's 2027 Outlook

JLL Sues Ex-Life Sciences Leader, Alleging Breach Of Noncompete

Cushman & Wakefield, NYC Added To Suit Alleging $250K Agency Lease Shakedown

FoxRock Buys Quincy Office At 78% Discount After Luring Tenant Away